Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Biogen Inc

Recent news which mentions Biogen Inc

< Previous 1 2 3 4 Next >
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
Tags GSK plc Biogen Inc Pfizer Inc
From CNBC.com News
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
Tags Companies Biogen Inc Health care industry
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Economy Technology CVS Health Corp
From CNBC.com News
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
Tags Companies Health care industry Biogen Inc
From CNBC.com News
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
Tags Companies Breaking news Biogen Inc
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags Toll Brothers Inc Caterpillar Inc Stock markets
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Berkshire Hathaway Inc Markets Politics
From CNBC.com News
Thursday's big stock stories: What's likely to move the market in the next trading session
Tags WABTEC CORP DRN Stock markets Pentair PLC
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Business News Boeing Co Norfolk Southern Corp
From CNBC.com News
Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
Tags Companies Breaking news Alzheimer's disease
From CNBC.com News
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
Tags Breaking news Companies Health care industry
From CNBC.com News
Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
Tags Biotechnology Business Eisai Co Ltd
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
Tags Biogen Inc Health care industry Companies
From CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
Tags Science Eli Lilly and Co US: News
From CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
Tags Stock Picks Business News stocks
From CNBC.com News
Cramer's Lightning Round: Bank of America is a buy
Tags Fidelis Insurance Holdings Ltd Markets Investment strategy
From CNBC.com News
Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
Tags US: News Eisai Co Ltd Business
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Microsoft Corp Li Auto Inc Economy
From CNBC.com News
Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
Tags Companies Biogen Inc Health care industry
From CNBC.com News
Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start
Tags Science Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
Tags Biogen Inc Health care industry Companies
From CNBC.com News
5 things to know before the stock market opens Monday
Tags DraftKings Inc Investing Technology
From CNBC.com News
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
Tags Science US: News Health & Science
From CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
Tags Pharmaceuticals Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Investment strategy MGM Resorts International Markets
From CNBC.com News
More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study
Tags Biogen Inc Health care industry Companies
From CNBC.com News
Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug
Tags Pharmaceuticals Biotech and Pharmaceuticals Depression
From CNBC.com News
Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more
Tags Sweetgreen Inc Business Stock markets
From CNBC.com News
Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
Tags Biogen Inc Spotify Technology SA Progressive Corp
From CNBC.com News
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
Tags Pharmaceuticals Biotech and Pharmaceuticals Health care industry
From CNBC.com News
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.